• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139401
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Pericardial Effusion (3271)
Date of Event 11/21/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during a bwi-sponsored clinical study a patient underwent an index cardiac ablation with a qdot micro catheter and experienced pleural effusion post-ablation.The issue was categorized as moderate and serious with prolonged hospitalization.The patient was originally admitted on (b)(6) 2025, had their procedure on (b)(6) 2025, and was discharged on (b)(6) 2025.It was determined that the event was not related to the qdot micro catheter or other devices used.Additionally, the relationship between the procedure itself and the event is that the effusion was a possibility but that its occurrence was unexpected/unanticipated.The patient was treated with the medication furosemide, and their issue was confirmed to be resolved by (b)(6) 2026.
 
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Additional Manufacturer Narrative
Per internal review on 20-feb-2026, it was determined that this event is not fda-reportable.There is no information to report as prior to the initial report's submission, bwi received information (on 13-feb-2026) that the effusion was not related to the products used in the procedure.This event was mistakenly reported and no further reports will be sent.Manufacturer reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key24380596
Report Number2029046-2026-00541
Device Sequence Number10568018
Product Code OAE
UDI-Device Identifier10846835017045
UDI-Public(01)10846835017045(11)250903(17)280902(10)31749719L
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P210027
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Study,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/20/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD139401
Device Lot Number31749719L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/26/2026
Supplement Date Received by Manufacturer02/20/2026
Initial Report FDA Received Date02/18/2026
Supplement Report FDA Received Date02/20/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/03/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention; Hospitalization;
Patient Age66 YR
Patient SexMale
Patient Weight125 KG
-
-